Navigation Links
Schizophrenia Drugs May Spur Subtle Brain Tissue Loss
Date:2/7/2011

MONDAY, Feb. 7 (HealthDay News) -- The use of antipsychotic drugs to treat schizophrenia is associated with the loss of a small but measurable amount of brain tissue, a new study finds.

It included 211 schizophrenia patients who each underwent an average of three MRI brain scans over 7.2 years, for a total of 674 scans in the study group. The researchers then examined how four factors affected changes in brain volume over time: illness duration, illness severity, substance abuse and treatment with antipsychotic drugs.

Longer duration of illness and antipsychotic treatment were both associated with loss of brain tissue. Higher doses of antipsychotics were associated with overall brain tissue loss, reduced gray matter and progressive declines in white matter.

Illness severity and substance abuse had little or no association with brain tissue changes, according to the study, published in the February issue of the Archives of General Psychiatry.

Among young adults, schizophrenia is a leading cause of chronic disability, according to background information in the study. Loss of brain volume in these patients was previously thought to be caused by the illness.

While antipsychotic drugs may lead to brain tissue loss, the benefits of long-term treatment may outweigh the risks, wrote the researchers at the University of Iowa Carver College of Medicine in Iowa City.

"However, our findings point toward the importance of prescribing the lowest doses necessary to control symptoms," they added in a news release from the journal's publisher.

The findings also raise concerns about prescribing antipsychotic drugs for patients with mental health conditions other than schizophrenia, such as bipolar disorder or depression.

The findings shouldn't be seem as a reason to halt the use of antipsychotic drugs to treat schizophrenia, Dr. David A. Lewis, of the University of Pittsburgh, wrote in an accompanying editorial.

"But they do highlight the need to closely monitor the benefits and adverse effects of these medications in individual patients, to prescribe the minimal amount needed to achieve the therapeutic goal, to consider the addition of non-pharmacological approaches that may improve outcomes and to continue the pursuit of new antipsychotic medications with different mechanisms of action and more favorable benefit to harm ratios," he wrote.

More information

The U.S. National Institute of Mental Health has more about schizophrenia.

-- Robert Preidt

SOURCE: JAMA/Archives journals, news release, Feb. 7, 2011


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Why symptoms of schizophrenia emerge in young adulthood
2. Mothers flu during pregnancy may increase babys risk of schizophrenia
3. Working-Memory Gene Linked to Schizophrenia
4. Scientists find gene linked to schizophrenia
5. Cold sore virus may contribute to cognitive and brain abnormalities in schizophrenia
6. Brain signs of schizophrenia found in babies
7. New book offers cutting-edge perspective on causes of schizophrenia; related disorders
8. EEG predicts response to medication for schizophrenia
9. Combining medication and psychosocial treatments may benefit patients with early-stage schizophrenia
10. Ming T. Tsuang recognized with NARSAD outstanding achievement award for schizophrenia research
11. Genetic Deletion Linked to Raised Risk of Autism, Schizophrenia
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Schizophrenia Drugs May Spur Subtle Brain Tissue Loss 
(Date:4/29/2016)... ... April 29, 2016 , ... ... flexibility in repaying their loans, more information about their loan terms and accounts, ... outstanding student loan debt, including federal and private loans, has reached $1.3 trillion, ...
(Date:4/29/2016)... ... April 29, 2016 , ... A ... born with severe congenital diaphragmatic hernia have better survival rates if surgery is ... hernia (CDH)—a condition where the diaphragm fails to form completely, letting abdominal organs ...
(Date:4/29/2016)... Kansas City, Missouri (PRWEB) , ... April 29, 2016 , ... ... Unlike traditional crutches which put pressure on the armpits, the M+D Crutch evenly distributes ... less strain on their wrists and hands when using the crutches than with other ...
(Date:4/29/2016)... ... 29, 2016 , ... Melanoma is the deadliest type of skin cancer. Although only about 1 ... skin cancer deaths. More than 10,000 people are expected to die of melanoma this year. ... is the one of the most commonly diagnosed cancers in young women. A recent breakthrough ...
(Date:4/29/2016)... ... ... Reltok Nasal Products proudly announces that Boston Medical Products, Inc., a leading ... specialty, has added the KOTLER NASAL AIRWAY™ to its diverse product line. , A ... safety device secured by nasal surgeons onto the floor of the nasal passages, at ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... , April 28, 2016  The blood testing market ... dollars, according to Kalorama Information and The Freedonia Group ... and nucleic acid testing.  The healthcare research firm said ... in developing blood collection stations and in improving testing ... Kalorama Information,s report, Blood Testing Market in ...
(Date:4/28/2016)... , April 28, 2016 Dr. ... and Ste phen ... ArisGlobal®, a leading provider of cloud-based software solutions for life ... Pharmacovigilance team to bring a wealth of insight to a growing ... pharmacovigilance knowledge. George Phillips joined ArisGlobal in ...
(Date:4/28/2016)... 28, 2016  ValGenesis, Inc., the market ... (VLMS) today announced that a prominent world ... of chronic kidney failure has selected ValGenesis ... corporate validation process. The global medical device ... to manage their validation processes electronically. Upon ...
Breaking Medicine Technology: